Financial News
NASDAQ:BLUE Shareholder Notice: Lawsuit Alleges Misleading Statements by Bluebird Bio Inc
February 24, 2021 at 13:00 PM EST
San Diego, CA -- (SBWIRE) -- 02/24/2021 -- An investor, who purchased shares of bluebird bio Inc (NASDAQ:BLUE), filed a lawsuit over alleged violations of Federal Securities Laws by bluebird bio Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
